IP Verse

Beigene competitive analysis

Latest publications and patents of Beigene New

Explore the latest publications and patents granted to Beigene, showcasing their recent innovations and technological advancements.

Last updated on: Sep 28, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Beigene
EP3500299	Dec 13, 2023	Use Of A Combination Comprising A Btk Inhibitor For Treating Cancers	Granted And Under Opposition
EP3013797	Jan 3, 2018	Fused Tricyclic Amide Compounds As Multiple Kinase Inhibitors	No Opposition Filed Within Time Limit

Latest patents of Beigene opposed by its competitors

Explore Beigene's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP3500299	Dec 13, 2023	Use Of A Combination Comprising A Btk Inhibitor For Treating Cancers	2

Latest PTAB cases involving Beigene

Discover the latest PTAB cases involving Beigene, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 4, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Beigene
PGR2024-00009	Nov 1, 2023	BEIGENE USA	PHARMACYCLICS	Final Written Decision

Peer Comparison New

IP litigation analysis comparing Beigene with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
BEIGENE	-	2	-	-	Non-Active
KERNEBECK PATENTANWALTS	1	-	-	-	Highly Aggressive
TEVA PHARMACEUTICALS	205	15	-	12	Highly Aggressive